angiotensin ii has been researched along with Acute Coronary Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agra, RM; Almengló, C; Álvarez, E; Couselo-Seijas, M; Eiras, S; García-Acuña, JM; González-Juanatey, JR; González-Peteiro, M; Varela-Román, A | 1 |
| Al-Aubaidy, HA; Al-Janabi, HS; Ghafil, FA; Hadi, NR; Mohammad, BI | 1 |
| Abbas, M; Abou-Merhi, R; Amoura, L; Auger, C; Chakfe, N; Georg, Y; Hamade, E; Hecker, M; Jesel, L; León-González, AJ; Manin, G; Messas, N; Morel, O; Ohlmann, P; Ribeiro, TP; Rumig, C; Schini-Kerth, VB; Silva, GC; Toti, F | 1 |
| Ceconi, C; Ferrari, R; Guardigli, G | 1 |
1 review(s) available for angiotensin ii and Acute Coronary Syndrome
| Article | Year |
|---|---|
Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.
Topics: Acute Coronary Syndrome; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Atherosclerosis; Bradykinin; Cardiotonic Agents; Coronary Artery Disease; Disease Progression; Endothelial Cells; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Perindopril; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention; Stem Cells | 2010 |
3 other study(ies) available for angiotensin ii and Acute Coronary Syndrome
| Article | Year |
|---|---|
Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value.
Topics: Acute Coronary Syndrome; ADAM17 Protein; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Enalapril; Female; Heart Failure; Human Umbilical Vein Endothelial Cells; Humans; Kaplan-Meier Estimate; Losartan; Male; Metoprolol; Middle Aged; Peptidyl-Dipeptidase A; Prognosis | 2021 |
Genetic polymorphism of angiotensin converting enzyme and angiotensin II type 1 receptors and their impact on the outcome of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Case-Control Studies; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Treatment Outcome | 2020 |
Endothelial Microparticles From Acute Coronary Syndrome Patients Induce Premature Coronary Artery Endothelial Cell Aging and Thrombogenicity: Role of the Ang II/AT1 Receptor/NADPH Oxidase-Mediated Activation of MAPKs and PI3-Kinase Pathways.
Topics: Acute Coronary Syndrome; Angiotensin II; Cellular Senescence; Humans; MAP Kinase Kinase 1; NADPH Oxidases; Phosphatidylinositol 3-Kinases; Risk Factors | 2017 |